http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3998098

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 438
issn 2223-3652
2223-3660
issueIdentifier 5
pageRange 431-438
publicationName Cardiovascular Diagnosis and Therapy
startingPage 431
bibliographicCitation Kataoka Y, Hosoda K, Makino H, Matsubara M, Matsuo M, Ohata Y, Koezuka R, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Son C, Nishimura K, Asaumi Y, Miyamoto Y, Noguchi T, Yasuda S. The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL). Cardiovasc Diagn Ther. 2019 Oct;9(5):431–8. PMID: 31737515; PMCID: PMC6837914.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_967c3374605b9f9aca4e014cf690bfe5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ba08a5ea4b1e0af0981cdb55fa3e5c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c19703a159b9904b4f1768091ec8232
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efefa0b733d7ef83d83480b61db52dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51cde5fdb7588d92bb4b6607fdebc477
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d807ac6f94097cb8251ea4d731622ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f55ace720a1f779a8adcecff742775df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2724d3c1bec3cf4dfde9bf6e692ab2c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b94801aa49252e25df1f429306dd046
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e180d4efd57c428327dc81178305deb7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f527e64d9abe5b85b9bab644218395fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cab1569e5576922c2be86fdd36f9d13e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9009-7234
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b33276793b363ec6c52cc89781a22e47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1655d4a7684dded838f3a668c48b8427
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49eaabc13b4043ee5be76693b5a5ecf4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49415d1887acbefab9d5bae9455f8a32
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9d6f571cc453a93616384e0ba3e4bb0
date 201910
identifier https://pubmed.ncbi.nlm.nih.gov/31737515
https://pubmed.ncbi.nlm.nih.gov/PMC6837914
https://doi.org/10.21037/cdt.2019.09.02
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41021
https://portal.issn.org/resource/ISSN/2223-3660
https://portal.issn.org/resource/ISSN/2223-3652
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL)
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.61
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11263

Showing number of triples: 1 to 46 of 46.